Safety of a New Security Device in Patients With Implanted Cardiac Electronic Devices
NCT ID: NCT03264222
Last Updated: 2021-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
379 participants
INTERVENTIONAL
2017-05-01
2018-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety of Screening Procedures With Hand-held Metal Detectors Among Patients With Implanted Cardiac Rhythm Devices
NCT01369706
Examination of Implant´s Safety in an Electronic and Magnetic Field Environment
NCT01626261
Assessment of Electromagnetic Interference Between E-transportation and Cardiac Implantable Electronic Devices
NCT02252575
Evaluation of Interference Between Cell Phones and Implantable Cardioverter Defibrillators
NCT02330900
Implantable Cardioverter Defibrillators And Magnetic Resonance Imaging of the Heart at 1.5 Tesla
NCT00356239
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exposition to safety screening
One armed study with exposition to a new safety device (model QPS100) using radiofrequency technology
Security screening procedure
Screening procedure with security device (model QPS 100)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Security screening procedure
Screening procedure with security device (model QPS 100)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* low battery voltage of implanted cardiac electronic device
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bayerisches Staatsministerium für Wirtschaft
UNKNOWN
R & S GmbH und Co KG
UNKNOWN
Deutsches Herzzentrum Muenchen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christof Kolb, MD
Role: PRINCIPAL_INVESTIGATOR
Deutsches Herzzentrum München
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Deutsches Herzzentrum München
Munich, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lennerz C, O'Connor MJ, Blazek P, Weigand S, Grebmer C, Reif S, Friedrich L, Reents T, Bourier F, Schunkert H, Deisenhofer I, Kolb C. Modern Security Screening and Electromagnetic Interference With Cardiac Implantable Electronic Devices. J Am Coll Cardiol. 2020 Mar 17;75(10):1238-1239. doi: 10.1016/j.jacc.2020.01.012. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GER-EP-017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.